Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite Di Ltd (NASDAQ: CLBTW) delivers critical Digital Intelligence solutions for modern investigative challenges. This news hub provides stakeholders with essential updates about the company’s technological advancements, regulatory compliance, and market positioning.
Access consolidated information on product launches, partnership announcements, and financial disclosures relevant to CLBTW’s role in digital forensics and corporate investigations. Our curated collection serves investors and professionals needing to monitor developments in SaaS-based investigative tools, eDiscovery innovations, and cybersecurity capabilities.
Key updates include earnings reports, leadership changes, and technology patents across Cellebrite’s Case-to-Closure platform. All content undergoes strict verification to ensure accuracy and relevance for decision-makers in both public sector and corporate environments.
Bookmark this page for streamlined access to CLBTW’s latest developments in legally compliant data analysis solutions. Regularly updated to reflect the company’s progress in addressing evolving digital security demands.
Cellebrite DI Ltd. (Nasdaq: CLBT) announced the appointment of Mark Fitzsimons as Managing Director for its Asia-Pacific (APAC) operations, effective April 17, 2023. Based in Singapore, Fitzsimons brings over 25 years of B2B enterprise software sales and strategy experience, having previously worked with companies like Everise and Software AG.
The company's CEO, Yossi Carmil, emphasized Fitzsimons' expertise as critical for Cellebrite's growth in APAC, particularly in addressing law enforcement's digital investigation needs. Fitzsimons aims to enhance the company's mission by delivering exceptional digital intelligence solutions across the region.
Cellebrite (NASDAQ: CLBT) will announce its first-quarter 2023 financial results on May 10, 2023, before the market opens. Following the release, the company will host a live conference call at 8:30 a.m. ET to review the results and discuss its full-year outlook. Investors can access the call via phone at 203-518-9814 or through a live webcast. Historical financial data will also be made available on the company’s investor relations website. Cellebrite specializes in Digital Intelligence solutions, aimed at enhancing legal investigations and safeguarding community privacy.
Cellebrite has launched Pathfinder X, an advanced AI-enabled investigative analytics solution designed to enhance digital investigations. The software features cloud deployment through AWS and Azure, a hub and spoke deployment format for dispersed teams, and robust user management for security compliance. Pathfinder X improves data mapping and helps identify persons of interest from various data sources, streamlining investigations. The technology has already shown effectiveness in ongoing cases, including a recent investigation by the Lake Jackson Police Department. Notably, Cellebrite secured substantial contracts valued over $10 million with European and Australian police forces.
Cellebrite DI Ltd. (Nasdaq: CLBT) recently announced the integration of its LegalView Physical Analyzer with RelativityOne, aimed at enhancing the efficiency of corporate investigations. Scheduled for release in spring 2023, this add-on simplifies data collection and review from multiple mobile devices, addressing the growing demand for swift mobile data handling in legal contexts. Chris Brown from Relativity highlighted the integration's potential to optimize evidence management, while Ken Basore of Cellebrite emphasized its role in conserving resources and improving workflows for legal investigators. This collaboration is set to be showcased at Legalweek from March 20-23, 2023.
Cellebrite reported a strong financial performance for Q4 and the full year 2022, with Annual Recurring Revenue (ARR) reaching $249 million, up 33% year-over-year. Q4 revenue was $74 million, representing a 9% increase year-over-year, with subscription revenue at $62.3 million, up 24%. The company's recurring revenue retention rate stood at 130%. Adjusted EBITDA for Q4 was $16.1 million, achieving a 21.8% margin. For 2023, Cellebrite expects ARR to be between $300-$310 million and total revenue between $305-$315 million, indicating continued growth potential.
Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Intelligence solutions, announced a significant collaboration in Brazil with The Exodus Road, an anti-human trafficking nonprofit. In 2022, their joint efforts with Brazilian law enforcement resulted in nine operations that directly freed 152 trafficking survivors and led to the arrest of 20 traffickers. Cellebrite provided crucial funding and technology support to enhance the effectiveness of these operations. Both organizations emphasize the ongoing need to combat human trafficking, with Cellebrite committed to ongoing support and training for law enforcement.
